Atenolol
Atenolol is a beta blocker medication primarily used to treat high blood pressure and heart-associated chest pain. Atenolol, however, does not seem to improve mortality in those with high blood pressure. Other uses include the prevention of migraines and treatment of certain irregular heart beats. It is taken orally (by mouth) or by intravenous injection (injection into a vein). It can also be used with other blood pressure medications.
Clinical data | |
---|---|
Trade names | Tenormin, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684031 |
License data | |
Pregnancy category |
|
Routes of administration | oral, Intravenous (IV) |
Drug class | Selective β1 receptor antagonist |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 40–50% |
Protein binding | 6–16% |
Metabolism | Minimal |
Onset of action | IV : <5 minutes Oral: <1 hour |
Elimination half-life | 6–7 hours |
Duration of action | >24 hours |
Excretion | Urine (>85% IV, 50% oral) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.044.941 |
Chemical and physical data | |
Formula | C14H22N2O3 |
Molar mass | 266.341 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
SMILES
| |
| |
(verify) |
Common side effects include feeling tired, heart failure, dizziness, depression, and shortness of breath. Other serious side effects include bronchial spasm. Use is not recommended during pregnancy and alternative drugs are preferred when breastfeeding. It works by blocking β1-adrenergic receptors in the heart, thus decreasing the heart rate and workload.
Atenolol was patented in 1969 and approved for medical use in 1975. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2021, it was the 47th most commonly prescribed medication in the United States, with more than 14 million prescriptions.